Predictive testing of minors for Huntington's disease: The UK and Netherlands experiences

Oliver W. Quarrell, Angus J. Clarke, Cecilia Compton, Christine E. M. de Die-Smulders, Alan Fryer, Sian Jenkins, Nayana Lahiri, Rhona MacLeod, Zosia Miedzybrodzka, Patrick J. Morrison, Hannah Musgrave, Mary O'Driscoll, Mark Strong, Martine J. van Belzen, Sascha Vermeer, Corien C. Verschuuren-Bemelmans, Emilia K. Bijlsma

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommendation not to undertake predictive tests on those < 18 years. Exceptions are made but the extent of, and reasons for, deviation from the guidelines are unknown. The UK Huntington's Prediction Consortium has collected data annually on predictive tests undertaken from the 23 UK genetic centers. DNA analysis for HD in the Netherlands is centralized in the Laboratory for Diagnostic Genome Analysis in Leiden. In the UK, 60 tests were performed on minors between 1994 and 2015 representing 0.63% of the total number of tests performed. In the Netherlands, 23 tests were performed on minors between 1997 and 2016. The majority of the tests were performed on those aged 16 and 17 years for both countries (23% and 57% for the UK, and 26% and 57% for the Netherlands). Data on the reasons for testing were identified for 36 UK and 22 Netherlands cases and included: close to the age of 18 years, pregnancy, currently in local authority care and likely to have less support available after 18 years, person never having the capacity to consent and other miscellaneous reasons. This study documents the extent of HD testing of minors in the UK and the Netherlands and suggests that, in general, the recommendation is being followed. We provide some empirical evidence as to reasons why clinicians have departed from the recommendation. We do not advise changing the recommendation but suggest that testing of minors continues to be monitored.

Original languageEnglish
Pages (from-to)35 - 39
Number of pages5
JournalAmerican Journal of Medical Genetics. Part B, Neuropsychiatric Genetics
Volume177
Issue number1
Early online date2 Nov 2017
DOIs
Publication statusPublished - 30 Jan 2018

Fingerprint

Minors
Huntington Disease
Netherlands
Guidelines
Genome
Pregnancy
DNA

Keywords

  • CAG
  • children
  • genetic tests
  • teenagers

Cite this

Quarrell, O. W., Clarke, A. J., Compton, C., de Die-Smulders, C. E. M., Fryer, A., Jenkins, S., ... Bijlsma, E. K. (2018). Predictive testing of minors for Huntington's disease: The UK and Netherlands experiences. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 177(1), 35 - 39. https://doi.org/10.1002/ajmg.b.32582

Predictive testing of minors for Huntington's disease : The UK and Netherlands experiences. / Quarrell, Oliver W.; Clarke, Angus J.; Compton, Cecilia; de Die-Smulders, Christine E. M.; Fryer, Alan; Jenkins, Sian; Lahiri, Nayana; MacLeod, Rhona; Miedzybrodzka, Zosia; Morrison, Patrick J.; Musgrave, Hannah; O'Driscoll, Mary; Strong, Mark; van Belzen, Martine J.; Vermeer, Sascha; Verschuuren-Bemelmans, Corien C.; Bijlsma, Emilia K.

In: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, Vol. 177, No. 1, 30.01.2018, p. 35 - 39.

Research output: Contribution to journalArticle

Quarrell, OW, Clarke, AJ, Compton, C, de Die-Smulders, CEM, Fryer, A, Jenkins, S, Lahiri, N, MacLeod, R, Miedzybrodzka, Z, Morrison, PJ, Musgrave, H, O'Driscoll, M, Strong, M, van Belzen, MJ, Vermeer, S, Verschuuren-Bemelmans, CC & Bijlsma, EK 2018, 'Predictive testing of minors for Huntington's disease: The UK and Netherlands experiences', American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, vol. 177, no. 1, pp. 35 - 39. https://doi.org/10.1002/ajmg.b.32582
Quarrell, Oliver W. ; Clarke, Angus J. ; Compton, Cecilia ; de Die-Smulders, Christine E. M. ; Fryer, Alan ; Jenkins, Sian ; Lahiri, Nayana ; MacLeod, Rhona ; Miedzybrodzka, Zosia ; Morrison, Patrick J. ; Musgrave, Hannah ; O'Driscoll, Mary ; Strong, Mark ; van Belzen, Martine J. ; Vermeer, Sascha ; Verschuuren-Bemelmans, Corien C. ; Bijlsma, Emilia K. / Predictive testing of minors for Huntington's disease : The UK and Netherlands experiences. In: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2018 ; Vol. 177, No. 1. pp. 35 - 39.
@article{f434604ebf5d496e86ac248d9bc52483,
title = "Predictive testing of minors for Huntington's disease: The UK and Netherlands experiences",
abstract = "A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommendation not to undertake predictive tests on those < 18 years. Exceptions are made but the extent of, and reasons for, deviation from the guidelines are unknown. The UK Huntington's Prediction Consortium has collected data annually on predictive tests undertaken from the 23 UK genetic centers. DNA analysis for HD in the Netherlands is centralized in the Laboratory for Diagnostic Genome Analysis in Leiden. In the UK, 60 tests were performed on minors between 1994 and 2015 representing 0.63{\%} of the total number of tests performed. In the Netherlands, 23 tests were performed on minors between 1997 and 2016. The majority of the tests were performed on those aged 16 and 17 years for both countries (23{\%} and 57{\%} for the UK, and 26{\%} and 57{\%} for the Netherlands). Data on the reasons for testing were identified for 36 UK and 22 Netherlands cases and included: close to the age of 18 years, pregnancy, currently in local authority care and likely to have less support available after 18 years, person never having the capacity to consent and other miscellaneous reasons. This study documents the extent of HD testing of minors in the UK and the Netherlands and suggests that, in general, the recommendation is being followed. We provide some empirical evidence as to reasons why clinicians have departed from the recommendation. We do not advise changing the recommendation but suggest that testing of minors continues to be monitored.",
keywords = "CAG, children, genetic tests, teenagers",
author = "Quarrell, {Oliver W.} and Clarke, {Angus J.} and Cecilia Compton and {de Die-Smulders}, {Christine E. M.} and Alan Fryer and Sian Jenkins and Nayana Lahiri and Rhona MacLeod and Zosia Miedzybrodzka and Morrison, {Patrick J.} and Hannah Musgrave and Mary O'Driscoll and Mark Strong and {van Belzen}, {Martine J.} and Sascha Vermeer and Verschuuren-Bemelmans, {Corien C.} and Bijlsma, {Emilia K.}",
note = "{\circledC} 2017 Wiley Periodicals, Inc.",
year = "2018",
month = "1",
day = "30",
doi = "10.1002/ajmg.b.32582",
language = "English",
volume = "177",
pages = "35 -- 39",
journal = "American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley",
number = "1",

}

TY - JOUR

T1 - Predictive testing of minors for Huntington's disease

T2 - The UK and Netherlands experiences

AU - Quarrell, Oliver W.

AU - Clarke, Angus J.

AU - Compton, Cecilia

AU - de Die-Smulders, Christine E. M.

AU - Fryer, Alan

AU - Jenkins, Sian

AU - Lahiri, Nayana

AU - MacLeod, Rhona

AU - Miedzybrodzka, Zosia

AU - Morrison, Patrick J.

AU - Musgrave, Hannah

AU - O'Driscoll, Mary

AU - Strong, Mark

AU - van Belzen, Martine J.

AU - Vermeer, Sascha

AU - Verschuuren-Bemelmans, Corien C.

AU - Bijlsma, Emilia K.

N1 - © 2017 Wiley Periodicals, Inc.

PY - 2018/1/30

Y1 - 2018/1/30

N2 - A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommendation not to undertake predictive tests on those < 18 years. Exceptions are made but the extent of, and reasons for, deviation from the guidelines are unknown. The UK Huntington's Prediction Consortium has collected data annually on predictive tests undertaken from the 23 UK genetic centers. DNA analysis for HD in the Netherlands is centralized in the Laboratory for Diagnostic Genome Analysis in Leiden. In the UK, 60 tests were performed on minors between 1994 and 2015 representing 0.63% of the total number of tests performed. In the Netherlands, 23 tests were performed on minors between 1997 and 2016. The majority of the tests were performed on those aged 16 and 17 years for both countries (23% and 57% for the UK, and 26% and 57% for the Netherlands). Data on the reasons for testing were identified for 36 UK and 22 Netherlands cases and included: close to the age of 18 years, pregnancy, currently in local authority care and likely to have less support available after 18 years, person never having the capacity to consent and other miscellaneous reasons. This study documents the extent of HD testing of minors in the UK and the Netherlands and suggests that, in general, the recommendation is being followed. We provide some empirical evidence as to reasons why clinicians have departed from the recommendation. We do not advise changing the recommendation but suggest that testing of minors continues to be monitored.

AB - A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommendation not to undertake predictive tests on those < 18 years. Exceptions are made but the extent of, and reasons for, deviation from the guidelines are unknown. The UK Huntington's Prediction Consortium has collected data annually on predictive tests undertaken from the 23 UK genetic centers. DNA analysis for HD in the Netherlands is centralized in the Laboratory for Diagnostic Genome Analysis in Leiden. In the UK, 60 tests were performed on minors between 1994 and 2015 representing 0.63% of the total number of tests performed. In the Netherlands, 23 tests were performed on minors between 1997 and 2016. The majority of the tests were performed on those aged 16 and 17 years for both countries (23% and 57% for the UK, and 26% and 57% for the Netherlands). Data on the reasons for testing were identified for 36 UK and 22 Netherlands cases and included: close to the age of 18 years, pregnancy, currently in local authority care and likely to have less support available after 18 years, person never having the capacity to consent and other miscellaneous reasons. This study documents the extent of HD testing of minors in the UK and the Netherlands and suggests that, in general, the recommendation is being followed. We provide some empirical evidence as to reasons why clinicians have departed from the recommendation. We do not advise changing the recommendation but suggest that testing of minors continues to be monitored.

KW - CAG

KW - children

KW - genetic tests

KW - teenagers

U2 - 10.1002/ajmg.b.32582

DO - 10.1002/ajmg.b.32582

M3 - Article

C2 - 29095566

VL - 177

SP - 35

EP - 39

JO - American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics

JF - American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics

SN - 1552-4841

IS - 1

ER -